Nicola Mikulcik Ohrner
Corporate Officer/Principal en FORMYCON AG .
Cargos activos de Nicola Mikulcik Ohrner
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| FORMYCON AG | Corporate Officer/Principal | 01/06/2022 | - |
bioeq GmbH
 bioeq GmbH Pharmaceuticals: MajorHealth Technology bioeq GmbH develops biosimilar drugs. The company was founded in March 2014 and is headquartered in Holzkirchen, Germany. | Director Ejecutivo | - | - |
Bioeq AG
 Bioeq AG Pharmaceuticals: MajorHealth Technology Bioeq AG operates as a biopharmaceutical company, which licenses, develops and commercializes biological successor products. It offers FYB201, an advanced biosimilar program intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases. The company is headquartered in Zug, Switzerland. | Director/Miembro de la Junta | - | - |
Historial de carrera de Nicola Mikulcik Ohrner
Estadísticas
Internacional
| Alemania | 3 |
| Suiza | 2 |
Operativa
| Chief Executive Officer | 1 |
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| FORMYCON AG | Health Technology |
| Empresas privadas | 2 |
|---|---|
Bioeq AG
Bioeq AG Pharmaceuticals: MajorHealth Technology Bioeq AG operates as a biopharmaceutical company, which licenses, develops and commercializes biological successor products. It offers FYB201, an advanced biosimilar program intended for use in place of existing, branded biologics to treat a range of chronic and often life-threatening diseases. The company is headquartered in Zug, Switzerland. | Health Technology |
bioeq GmbH
bioeq GmbH Pharmaceuticals: MajorHealth Technology bioeq GmbH develops biosimilar drugs. The company was founded in March 2014 and is headquartered in Holzkirchen, Germany. | Health Technology |
